U.S., Japan & Europe Computer Aided Detection (CAD) Market, By Product Type (Software and Services), Imaging Modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of Purchase (Group Purchase Organization and Individual), End User (Hospitals, Diagnostic Centers, Research Institutes and Academic Centers, and Others) - Industry Trends and Forecast to 2031.
U.S., Japan and Europe Computer Aided Detection (CAD) Market Analysis and Size
The U.S., Japan & Europe Computer Aided Detection (CAD) market is expected to gain market growth in the forecast period of 2024 to 2031.
Data Bridge Market Research analyses that the market is growing with a CAGR of 12% in the forecast period of 2024 to 2031 and is expected to reach USD 3,609.06 Million by 2031. Increasing demand for CAD systems is expected to drive the market's expansion.
|
Report Metric
|
Details
|
|
Forecast Period
|
2024 to 2031
|
|
Base Year
|
2023
|
|
Historic Year
|
2022 (Customizable 2016-2021)
|
|
Quantitative Units
|
Revenue in USD Million and Pricing in USD
|
|
Segments Covered
|
Product Type (Software and Services), Imaging modality (Breast Imaging, Lung Imaging, Oncology and Radiation, Abdominal and Pelvic Imaging, Dental Imaging, Cardiovascular Imaging, and Others), Application (Cancer, Neurological Disorders, Cardiovascular Diseases, Musculoskeletal Diseases, and Others), Mode of purchase (Group Purchase Organization and Individual), End user (Hospitals, Diagnostic Centers, Research Institutes and Academic Centers, and Others)
|
|
Countries Covered
|
U.S., Japan, Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands and rest of Europe
|
|
Market Players Covered
|
CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips N.V., Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD, and Inc., EDDA Technology, Inc. among others
|
Market Definition
The term "computer-aided detection" (CAD) describes the process of interpreting medical imaging investigations, such as X-rays, CT scans, and MRIs, by using computer algorithms and software. Areas of interest or possible abnormalities in the images are highlighted and flagged by CAD systems so that a radiologist or other healthcare provider can investigate them further. These systems analyze patterns, shapes, and densities in the images to increase diagnosis efficiency and accuracy by highlighting areas that could need more examination. CAD is a useful tool in the diagnosis process that helps medical professionals comprehend and make decisions, even if it cannot replace human skills.
U.S., Japan and Europe Computer Aided Detection (CAD) Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints, and challenges. All of this is discussed in detail below:
Drivers
Rising Application of Computer-Aided Detection (CAD) System in the Medical Field
The market for computer-aided detection (CAD) systems is growing and evolving due to the growing implementation of these systems in various medical disciplines. CAD systems were widely used in radiology to identify complexities in images, such as mammograms, but they have quickly spread to many other medical specialties. The growing use of CAD systems in specialty areas other than radiology—pathology, cardiology, oncology, and neurology—indicates their adaptability and effectiveness in supporting medical personnel in a variety of disciplines. Healthcare procedures are being revolutionized by CAD's capacity to provide early identification, precise diagnosis, and treatment planning for a variety of illnesses.
The increasing adoption and use of CAD systems in a range of medical specialties highlights their revolutionary influence on the provision of healthcare. The use of these systems in a variety of specializations is growing as they show promise in facilitating earlier and more accurate diagnoses, improved treatment outcomes, and improved patient care. Thus, the rising application of CAD system in medical field is driving market growth.
- Increasing Technological Advancements Associated with CAD
The primary factor behind the growth and expansion of the computer-aided detection (CAD) market in the healthcare sector is technological improvements. These developments keep CAD systems up to date and improve their adaptability, precision, and capacity for diagnosing a wide range of medical disorders. The development of deep learning algorithms, machine learning, and artificial intelligence (AI) has been essential to the advancement of CAD systems. These developments make it possible for CAD software to process enormous volumes of medical imaging data at previously unheard-of speeds and precision. This results in the more accurate and dependable identification of anomalies in MRIs, CT scans, X-rays, and other imaging modalities.
CAD systems will advance in detection, adaptability, and integration with healthcare ecosystems as technological advancements continue. The market is growing as a result of the CAD industry's unwavering application of technology improvements, which have the enormous potential to revolutionize patient care, improve diagnostic capabilities, and influence the direction of healthcare. Thus, the increasing technological advancements is driving market growth.
Opportunities
- Advanced Healthcare Infrastructure of the Countries
The advanced healthcare infrastructure in the U.S., Japan, and Europe is a factor for creating significant opportunities in the market. In the U.S., the well-established network of hospitals and diagnostic centers, coupled with sophisticated medical facilities, provides a fertile ground for the seamless integration of CAD technologies. The robust infrastructure accelerates the adoption of CAD systems, enhancing the efficiency and accuracy of medical imaging and diagnostics.
In all three regions, the advanced healthcare infrastructure not only establishes a foundation for the implementation of CAD but also reflects a commitment to leveraging cutting-edge technologies to enhance patient care. This commitment, combined with the technological readiness of healthcare systems, creates an environment where CAD can thrive, offering advanced diagnostic capabilities that contribute to more accurate and timely medical interventions, which is expected to create opportunities for market growth.
Restraints/Challenge
- High Cost of Computer Aided Detection (CAD) Systems
Many healthcare facilities find it difficult to integrate CAD systems into their diagnostic workflows due to the initial investment necessary for CAD system acquisition and implementation. Medical imaging-specific hardware and software are frequently needed for CAD systems. These systems might have expensive upfront costs, particularly for smaller healthcare facilities or those with tighter budgets.
The total cost of ownership includes additional expenses for continuing maintenance, updates, and licensing after the initial expenditure. The cost is increased by having to make sure the system is current with new developments and complies with legal requirements. It takes more time and resources to train healthcare workers on how to utilize CAD systems efficiently and seamlessly integrate them into current operations. There are expenses associated with this training for both the initial deployment and ongoing instruction as new features or updates are released.
Healthcare providers, especially smaller practices or institutions with limited funds, have been reluctant to use CAD systems due to their high cost. Patients' access to the advantages of CAD systems' more precise and effective diagnoses is restricted by this adoption barrier. The financial resources of healthcare institutions, particularly smaller practices or those with low resources, are strained by the cumulative effect of maintenance expenditures. Thus, the high cost of computer aided detection ((CAD) systems is restraining the market growth.
U.S., Japan and Europe Computer Aided Detection (CAD) Market Scope
The U.S., Japan & Europe Computer Aided Detection (CAD) Market is segmented into five notable segments based on product type, imaging modality, mode of purchase, and end user.
Product Type
- Software
- Services
On the basis of product type, the market is segmented software and services.
Imaging Modality
- Breast Imaging
- Lung Imaging
- Oncology and Radiation
- Abdominal and Pelvic Imaging
- Dental Imaging
- Cardiovascular Imaging
- Others
On the basis of imaging modality, the market is segmented into breast imaging, lung imaging, oncology and radiation, abdominal and pelvic imaging, dental imaging, cardiovascular imaging, and others.
Application
- Cancer
- Neurological Disorders
- Cardiovascular Diseases
- Musculoskeletal Diseases
- Others
On the basis of application, the market is segmented into cancer, neurological disorders, cardiovascular diseases, musculoskeletal diseases, and others.
Mode of Purchase
- Group Purchase Organization
- Individual
On the basis of mode of purchase, the market is segmented into group purchase organization and individual.
End User
- Hospitals
- Diagnostic Centers
- Research Institutes and Academic Centers
- Others
On the basis of end user, the market is segmented into hospitals, diagnostic centers, research institutes and academic centers, and others.
U.S., Japan and Europe Computer Aided Detection (CAD) Market Regional Analysis/Insights
The U.S., Japan & Europe Computer Aided Detection (CAD) market is analyzed, and market size insights and trends are provided by based on product type, imaging modality, application, mode of purchase, and end user.
The countries covered in the U.S., Japan & Europe Computer Aided Detection (CAD) Market report are U.S., Germany, Italy, U.K., France, Switzerland, Spain, Russia, Turkey, Belgium, Netherlands, and rest of Europe.
U.S. is expected to dominate the North American market because the U.S. is one of the world's largest producers of CAD systems. Japan is expected to dominate the Asia-Pacific market due to it has a long history of medical technologies. Germany is expected to dominate the market due to German medical professionals often employ modern and efficient CAD practices, which can lead to higher sales and better-quality CAD.
The country section of the report also provides individual market-impacting factors and changes in market regulation that impact the current and future trends of the market. Data points like downstream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of Global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and U.S., Japan and Europe Computer Aided Detection (CAD) Market Share Analysis
The U.S., Japan & Europe Computer Aided Detection (CAD) market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, Global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus on the U.S., Japan & Europe Computer Aided Detection (CAD) market.
Some of the major players operating in the U.S., Japan & Europe Computer Aided Detection (CAD) market are CANON MEDICAL SYATEMA CORPORATION, Riverain Technologies, Koninklijke Philips N.V., Seimens Healthineers AG, Hologic Inc., FUJIFILM Holdings Corporation, Median Technologies, General Electric Company, iCAD, and Inc., EDDA Technology, Inc.
SKU-